Billybob, I went to this website, https://www.ascopost.com/search-results/?q=vitamin+d+and+cancer hoping to find the studies you reference. Unfortunately, to my surprise, I found a mixed bag
Yes it does look like a mixed bag. Before I start reading them all, do you know if these are the new studies the article I posted was referring to? Some of these, based on the titles, seem very familiar for some reason, like I might have already posted about
them before. If so, then at least one of these declared to show no benefit will indeed show some benefit, but might not quite rise to statistical significance(SS) for the main outcome, that sort of thing. And one of those was on terminal patients on there last days, where starting vitamin D al that late date bought them a few months, but maybe still not SS. But I'm going to have a look mainly to see if this includes these new studies.
EDIT: Yep, the very first one I see is one of the studies I have covered before. Headline is "no benefit", but considering the helpless of the circumstances, I thought the results were notable. And makes you wonder if thet had started 10 years earlier, rather than when they only had a year to live:
"In the high-dose group, median progression-free survival was 13 vs 11 months in the standard-dose group.
Patients in the high-dose vitamin D group were 36% less likely to have disease progression or death during the follow-up period of 22.9 months.
There were no significant differences between the high-dose and standard-dose group in terms of tumor overall "response rate or overall survival............
The study and its findings are “extremely important,” Dr. Ng said, because “it identifies a cost-effective, safe, and easily accessible agent as a potential new treatment for metastatic colorectal cancer. This could therefore potentially have a large and wide-reaching impact globally, regardless of a patient’s socioeconomic status or a country’s resources.”" And yet, the headline is "There were no significant differences between the high-dose and standard-dose group in terms of tumor overall response rate or overall survival.". Oh yeah, not comparing 0 zero vitamin D, but only to "less" vitamin D.
Post Edited (BillyBob@388) : 6/4/2019 4:23:50 PM (GMT-6)